Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL622396 | 1.00 | HMGCR (0.31) | HMGCRCHRM1TBXA2RADRA1ACYP2D6 | |
| SCHEMBL5693456 | 0.81 | — | — | |
| SCHEMBL5965051 | 0.81 | — | — | |
| SCHEMBL622827 | 0.79 | LMNA (0.32) | — | |
| SCHEMBL622824 | 0.79 | LMNA (0.32) | — | |
| SCHEMBL8679666 | 0.77 | HMGCR (0.30) | HMGCRCHRM1TBXA2RADRA1A | |
| Chloromethane SCHEMBL219837 | 0.76 | ALDH1A1 (0.33) | TSHR | |
| SCHEMBL44909 | 0.75 | ALDH1A1 (0.36) | — | |
| SCHEMBL109778 | 0.75 | ALDH1A1 (0.36) | — | |
| Chloromethane SCHEMBL9414315 | 0.74 | ALDH1A1 (0.32) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2568967-B2 | PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROMORPHONE AND NALOXONE | EURO CELTIQUE SA (LU) | 2022-07-27 | — | — | EP | disclosed |
| US-20190224130-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROMORPHONE AND NALOXONE | PURDUE PHARMA (CA) | 2019-07-25 | — | — | US | disclosed |
| EP-3505162-A1 | USE OF BINDERS FOR MANUFACTURING STORAGE STABLE FORMULATIONS | Euro-Celtique S.A. (LU) | 2019-07-03 | — | — | EP | disclosed |
| EP-2568967-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROMORPHONE AND NALOXONE | EURO CELTIQUE SA (LU) | 2018-10-24 | — | — | EP | disclosed |
| EP-2603205-B1 | USE OF BINDERS FOR MANUFACTURING STORAGE STABLE FORMULATIONS | EURO CELTIQUE SA (LU) | 2018-10-03 | — | — | EP | disclosed |
| US-9993433-B2 | Manufacturing of active-free granules and tablets comprising the same | EURO-CELTIQUE S.A. (LU) | 2018-06-12 | — | — | US | disclosed |
| US-9901540-B2 | Combination of active loaded granules with additional actives | EURO-CELTIQUE S.A. (LU) | 2018-02-27 | — | — | US | disclosed |
| EP-2568968-B1 | Manufacturing of active-free granules and tablets comprising the same | EURO CELTIQUE SA (LU) | 2017-07-12 | — | — | EP | disclosed |
| US-9700508-B2 | Pharmaceutical compositions comprising hydromorphone and naloxone | EURO-CELTIQUE S.A. (GB) | 2017-07-11 | — | — | US | disclosed |
| US-20170182031-A1 | REDUCING DRUG LIKING IN A SUBJECT | PURDUE PHARMA (CA) | 2017-06-29 | — | — | US | disclosed |
| EP-2568967-A2 | PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROMORPHONE AND NALOXONE | Euro-Celtique S.A. (LU) | 2013-03-20 | — | — | EP | disclosed |
| WO-2012020097-A2 | USE OF BINDERS FOR MANUFACTURING STORAGE STABLE FORMULATIONS | EURO-CELTIQUE S.A. (LU) | 2012-02-16 | — | — | WO | disclosed |
| WO-2011141490-A1 | COMBINATION OF ACTIVE LOADED GRANULES WITH ADDITIONAL ACTIVES | EURO-CELTIQUE S.A. (LU) | 2011-11-17 | — | — | WO | disclosed |
| WO-2011141489-A1 | MANUFACTURING OF ACTIVE-FREE GRANULES AND TABLETS COMPRISING THE SAME | EURO-CELTIQUE S.A. (LU) | 2011-11-17 | — | — | WO | disclosed |
| WO-2011141488-A2 | PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROMORPHONE AND NALOXONE | EURO-CELTIQUE S.A. (LU) | 2011-11-17 | — | — | WO | disclosed |
| EP-1487882-B1 | BASE POLYMER OBTAINED BY HYDROGENATION | STOCKHAUSEN CHEM FAB GMBH (DE) | 2006-05-24 | — | — | EP | disclosed |
| US-20050215756-A1 | Basic polymer obtained by hydrogenation | STOCKHAUSEN GMBH (DE) | 2005-09-29 | — | — | US | disclosed |
| EP-1487882-A1 | BASE POLYMER OBTAINED BY HYDROGENATION | Stockhausen GmbH (DE) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003080682-A1 | BASE POLYMER OBTAINED BY HYDROGENATION | STOCKHAUSEN GMBH (DE) | 2003-10-02 | — | — | WO | disclosed |
| EP-0058765-B1 | COATING SOLUBLE OR SWELLABLE IN GASTRIC JUICE, AND ITS USE IN A PROCESS FOR COATING PHARMACEUTICAL PREPARATIONS | RÖHM GMBH (DE) | 1985-02-20 | — | — | EP | disclosed |